BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 20801002)

  • 1. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues in biosecurity and biosafety.
    Nordmann BD
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S66-9. PubMed ID: 20696555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
    Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
    Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosafety practices associated with potential agents of biocrime and biowarfare.
    Burnett LC
    Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
    Li XY; Xue KN; Jiang JS; Lu XC
    Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosafety news: introducing EBSA--the European Biosafety Association.
    Biotechnol J; 2007 Mar; 2(3):285. PubMed ID: 17354214
    [No Abstract]   [Full Text] [Related]  

  • 11. The basics of animal biosafety and biocontainment training.
    Pritt S; Hankenson FC; Wagner T; Tate M
    Lab Anim (NY); 2007 Jun; 36(6):31-8. PubMed ID: 17519943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
    Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
    Front Public Health; 2021; 9():766162. PubMed ID: 34976925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative impact of laws regarding biosecurity and bioterrorism on real diseases.
    Wurtz N; Grobusch MP; Raoult D
    Clin Microbiol Infect; 2014 Jun; 20(6):507-15. PubMed ID: 24909400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biosafety provision on handling pathogenic biological agents on the concept of biorisk assessment and management].
    Dobrokhotskiĭ ON; Kolombet LV
    Gig Sanit; 2010; (5):79-81. PubMed ID: 21344700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
    Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
    Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a national biological laboratory safety and security monitoring program.
    Blaine JW
    Biosecur Bioterror; 2012 Dec; 10(4):396-400. PubMed ID: 23210833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between biocontainment laboratories and their communities: a successful work in progress.
    Kanabrocki J
    Trends Microbiol; 2011 May; 19(5):209-10. PubMed ID: 21353566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
    Peng H; Bilal M; Iqbal HMN
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30501091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biorisk Management for Clinical Diagnostic Laboratories].
    Shigematsu M
    Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious waste management and laboratory design criteria.
    Zaki AN; Campbell JR
    Am Ind Hyg Assoc J; 1997 Nov; 58(11):800-8. PubMed ID: 9373926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.